In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The odds for aspiration is greatest in the first weeks after a GLP-1 med is prescribed, since the delay in stomach emptying ...

Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular weight loss drugs.

The active ingredient in Ozempic and Wegovy has once ... This effect was most stark when comparing semaglutide to the old-school diabetes injectable insulin, with patients on semaglutide showing ...

"If a patient has a BMI of 40 (meaning they're roughly 80 to 100 pounds overweight for their height) or a BMI of 35 with ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight ... even in patients without diabetes. Perhaps most striking was a 19% lower death rate from ...